[
  {
    "ts": null,
    "headline": "A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook",
    "summary": "Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the third quarter of 2025. A copy of the letter can be downloaded here. The portfolio underperformed in the quarter due to stock selection. The composite returned 5.02%, net of fees, compared to 7.62% for the MSCI AC […]",
    "url": "https://finnhub.io/api/news?id=ea54f89260cdd8c43bbd29310f199faccb81f44c517e4e046b080d978b38017e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766756952,
      "headline": "A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook",
      "id": 137908336,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” investor letter for the third quarter of 2025. A copy of the letter can be downloaded here. The portfolio underperformed in the quarter due to stock selection. The composite returned 5.02%, net of fees, compared to 7.62% for the MSCI AC […]",
      "url": "https://finnhub.io/api/news?id=ea54f89260cdd8c43bbd29310f199faccb81f44c517e4e046b080d978b38017e"
    }
  }
]